| scholarly article | Q13442814 |
| P2093 | author name string | Hashimoto H | |
| Suda T | |||
| Nagata S | |||
| Watanabe D | |||
| P2860 | cites work | Human Fas ligand: gene structure, chromosomal location and species specificity | Q24310150 |
| Isolation and characterization of the human chromosomal gene for polypeptide chain elongation factor-1 alpha | Q24317250 | ||
| Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity | Q24680778 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family | Q28285445 | ||
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand | Q28513283 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen | Q30988634 | ||
| Overexpression of src family gene for tyrosine-kinase p59fyn in CD4-CD8- T cells of mice with a lymphoproliferative disorder | Q34326573 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice | Q36129002 | ||
| Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide | Q36297378 | ||
| Association of lpr gene with graft-vs.-host disease-like syndrome | Q36350394 | ||
| Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules | Q36353797 | ||
| Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene | Q36362052 | ||
| The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr | Q36648389 | ||
| Lethal effect of the anti-Fas antibody in mice | Q36696599 | ||
| Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. | Q36772013 | ||
| Tyrosine phosphorylation of a c-Src-like protein is increased in membranes of CD4- CD8- T lymphocytes from lpr/lpr mice | Q36795299 | ||
| Purification and characterization of the Fas-ligand that induces apoptosis | Q38310834 | ||
| Abnormal antigen receptor-initiated signal transduction in lpr T lymphocytes | Q40388334 | ||
| Positive selection of lymphocytes | Q40807424 | ||
| Negative selection of lymphocytes | Q40807431 | ||
| An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity | Q42941505 | ||
| The autoimmune mouse MRL/Mp-lpr/lpr contains cells with spontaneous cytotoxic activity against target cells bearing self-determinants | Q43617051 | ||
| Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity | Q46094710 | ||
| Abnormal tyrosine phosphorylation on T-cell receptor in lymphoproliferative disorders | Q46673762 | ||
| Transcriptional Repression and Differential Splicing of Fas m-RNA by Early Transposon (ETn) Insertion in Autoimmune LPR Mice | Q48129187 | ||
| Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr | Q52070302 | ||
| Activation interferes with the APO-1 pathway in mature human T cells. | Q54239983 | ||
| Monoclonal antibody-mediated tumor regression by induction of apoptosis. | Q55059937 | ||
| Induction of Graft versus Host Disease in SCID Mice by MRL/lpr Cell Transfer | Q61883929 | ||
| DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement | Q67531812 | ||
| Autoimmunity and increased c-myb transcription | Q70659793 | ||
| Spontaneous and antibody directed cytotoxicity of double-negative T cells from autoimmune mice | Q70719375 | ||
| Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? | Q71617372 | ||
| Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect | Q72273666 | ||
| Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells | Q72921121 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 12-18 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders | |
| P478 | volume | 14 |
| Q34600681 | 'Activation-induced cell death': a special program able to preserve the homeostasis of the skin? |
| Q36368071 | A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation |
| Q36979743 | Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity |
| Q64018952 | Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice |
| Q33802379 | Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression |
| Q41289470 | Clonal deletion of major histocompatibility complex class I‐restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO‐1/Fas) ligand |
| Q33500292 | Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation. |
| Q36366324 | Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease |
| Q36339524 | Cytotoxic mechanisms employed by mouse T cells to destroy pancreatic β-cells. |
| Q35908961 | Death effectors of beta-cell apoptosis in type 1 diabetes |
| Q35716736 | Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions |
| Q37711034 | Enhanced and accelerated lymphoproliferation in Fas-null mice |
| Q35092580 | Enhanced contact allergen- and UVB-induced keratinocyte apoptosis in the absence of CD95/Fas/Apo-1 |
| Q35763713 | Enhanced lymphocyte longevity and absence of proliferation and lymphocyte apoptosis in Quilty effects of human heart allografts |
| Q40806057 | Expression of the functional soluble form of human fas ligand in activated lymphocytes. |
| Q35766053 | Fas activation increases neural progenitor cell survival |
| Q74623258 | Fas ligand (CD95 ligand) controls angiogenesis beneath the retina |
| Q53418059 | Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis. |
| Q71564585 | Fas receptor expression on B-lineage cells |
| Q57248069 | Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene |
| Q28584047 | Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB |
| Q34769749 | FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells |
| Q73320396 | Gender- and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice |
| Q42856573 | Identification of Fas-L-expressing apoptotic T lymphocytes in normal human peripheral blood : in vivo suicide |
| Q78644028 | Identification of a FasL-like molecule in leucocytes of the teleost fish gilthead seabream (Sparus aurata L.). |
| Q71708794 | Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo |
| Q40068662 | Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity. |
| Q36368261 | MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells |
| Q73101472 | MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways |
| Q36798787 | Mechanisms of beta cell death in diabetes: a minor role for CD95. |
| Q42093656 | Membrane-bound Fas ligand only is essential for Fas-induced apoptosis |
| Q34428954 | Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation |
| Q36706217 | Pathology and immunology of lupus glomerulonephritis: can we bridge the two? |
| Q37773421 | Programmed cell death of dendritic cells in immune regulation |
| Q41102922 | Role of Fas-mediated cell death in the regulation of immune responses |
| Q36399210 | T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis |
| Q59783966 | TNF-related ligands and their receptors |
| Q41515265 | The Fas pathway in apoptosis. |
| Q33434632 | The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis |
| Q37114374 | The dual functions of fas ligand in the regulation of peripheral CD8+ and CD4+ T cells |
| Q42944882 | The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. |
| Q34205697 | The many roles of FAS receptor signaling in the immune system |
| Q81094852 | The role of Fas ligand as an effector molecule in corneal graft rejection |
| Q79780583 | Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation |
| Q34462324 | beta-Cell death during progression to diabetes |
Search more.